Abnormalities in a protein called TDP-43, which is known to play a key role in the development of amyotrophic…
Articles by Marisa Wexler, MS
Throughout 2024, the team at Huntington’s Disease News covered the latest developments in research and news related to…
The U.S. Food and Drug Administration (FDA) has agreed that results from two ongoing Phase 1/2 clinical trials, compared with…
Beta-blockers, a class of medicines often used to manage heart and blood pressure issues, may slow the onset and progression…
Ingrezza (valbenazine), an approved treatment for chorea, or uncontrolled movements, related to Huntington’s disease, shows similar effectiveness…
Being physically active is significantly associated with a delayed age of the onset of Huntington’s disease and spending more…
Ingrezza Sprinkle, a new formulation of Ingrezza (valbenazine) that’s designed to be easier to swallow, is now available in…
Significant impairments in cognitive function are evident in people with Huntington’s disease relative to healthy adults, as assessed with…
Clinical trials testing either tominersen, an experimental therapy designed to target the underlying cause of Huntington’s disease, or…
The Huntington’s disease community was encouraged to step up and get involved in observational studies to help scientists better…